Back to calendar
REGENXBIO Inc. (RGNX) Earnings
RGNX reports earnings on Wednesday, November 11, 2026
earnings report
November 11, 2026 · Before Market Open
Q3 2026
Est. EPS: $-1.21
Actual EPS: $0.43
EPS surprise: 446.19%
Company overview
Market Cap$615.2M
PriceUSD 9.32
EPS (TTM)-3.79
52-week high16.19
52-week low5.46
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees371